Back
Viking Therapeutics Stock Price Chart

The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
45
VKTX
Viking Therapeutics
Last Price:
$26.99
Seasonality Move:
5.13%
7 Day Trial
ALL ACCESS PASS
$
7

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.57 | Sell |
20-day SMA: | 27.84 | Sell |
50-day SMA: | 26.38 | Buy |
200-day SMA: | 44.46 | Sell |
8-day EMA: | 27.57 | Sell |
20-day EMA: | 27.32 | Sell |
50-day EMA: | 27.74 | Sell |
200-day EMA: | 38.12 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 49.19 | Sell |
Chaikin Money Flow: | -1030209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.92 - 28.68) | Sell |
Bollinger Bands (100): | (24.74 - 34.96) | Sell |
Viking Therapeutics Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 26.98 while VKTX 8-day simple moving average is 27.57, which is a Sell signal.
-
The stock price of VKTX is 26.98 while Viking Therapeutics 20-day SMA is 27.84, which makes it a Sell.
-
Viking Therapeutics 50-day simple moving average is 26.38 while VKTX share price is 26.98, making it a Buy technically.
-
VKTX stock price is 26.98 and Viking Therapeutics 200-day simple moving average is 44.46, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $26.98. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
3B
Price in USD:
26.98
Share Volume:
1.8M
Viking Therapeutics 52-Week Range
52-Week High:
81.73
52-Week Low:
18.92
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 26.98 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 26.98 while VKTX 8-day exponential moving average is 27.57, which is a Sell signal.
-
The stock price of VKTX is 26.98 while Viking Therapeutics 20-day EMA is 27.32, which makes it a Sell.
-
Viking Therapeutics 50-day exponential moving average is 27.74 while VKTX share price is 26.98, making it a Sell technically.
-
VKTX stock price is 26.98 and Viking Therapeutics 200-day simple moving average is 38.12, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.28 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Viking Therapeutics is a Buy
-
Viking Therapeutics Relative Strength Index (RSI) is 49.19, which suggest Viking Therapeutics is oversold
-
The Bollinger Bands (25) for Viking Therapeutics is (25.92 - 28.68), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (24.74 - 34.96), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.